Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - hyoscine butylbromide, quantity: 20 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.

New Zealand - English - Medsafe (Medicines Safety Authority)

medsurge pharma limited - hyoscine butylbromide 20 mg/ml - solution for injection - 20 mg/ml - active: hyoscine butylbromide 20 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - muscle spasm of the gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - hyoscine butylbromide, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 10 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; acacia; white beeswax; calcium hydrogen phosphate dihydrate; stearic acid; maize starch; macrogol 6000; tartaric acid; purified talc; sucrose; povidone; carnauba wax; titanium dioxide; soluble maize starch - spasm of the gastrointestinal tract

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - hyoscine butylbromide, quantity: 20 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - spasm of the gastrointestinal tract.

Kenya - English - Pharmacy and Poisons Board

laborate pharmaceuticals india limited laborate pharmaceuticals india limited e-11 - hyoscine butylbromide - injection - each ml contains: hyoscine butylbromide bp 20mg - plain belladonna and derivatives: semisynthetic

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - hyoscine butylbromide -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - hyoscine-n-butylbromide - unknown - hyoscine-n-butylbromide alkaloid active 0.0 - active constituent

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - hyoscine butylbromide -